The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Borzova A.A.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Ampleenkova K.I.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Krot M.A.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Nefedova M.A.

State Scientific Center of Dermatovenereology and Cosmetology

Smolyannikova V.A.

The First Sechenov Moscow State Medical University (Sechenov University)

Filatov A.V.

The First Sechenov Moscow State Medical University (Sechenov University)

Dysplastic nevi: difficulties in diagnosis

Authors:

Borzova A.A., Ampleenkova K.I., Krot M.A., Nefedova M.A., Smolyannikova V.A., Filatov A.V.

More about the authors

Read: 422 times


To cite this article:

Borzova AA, Ampleenkova KI, Krot MA, Nefedova MA, Smolyannikova VA, Filatov AV. Dysplastic nevi: difficulties in diagnosis. Russian Journal of Archive of Pathology. 2025;87(6):12‑19. (In Russ.)
https://doi.org/10.17116/patol20258706112

Recommended articles:
Clinical and dermoscopic analysis of atypical sebo­rrheic kera­tosis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):64-71
Algo­rithms for morphological diagnostics of dysplastic nevus. P.A. Herzen Journal of Onco­logy. 2025;(2):83-88
Mela­noma of the maxi­llary sinus mucosa. Stomatology. 2025;(2):82-85
Function-sparing surgery for subu­ngual mela­noma in situ. Piro­gov Russian Journal of Surgery. 2025;(11):141-144
Fluorescent in situ-hybridization (FISH) in onco­logy. P.A. Herzen Journal of Onco­logy. 2025;(6):88-93

References:

  1. Goldstein AM, Tucker MA. Dysplastic nevi and melanoma. Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):528-532.  https://doi.org/10.1158/1055-9965.EPI-12-1346
  2. Clark WH, Reimer RR, Greene M, et al. Origin of familial malignant melanomas from heritable melanocytic lesions: «The B-K mole syndrome». Arch Dermatol. 1978;114(5):732-738.  https://doi.org/10.1001/archderm.1978.01640170032006
  3. Lynch HT, Frichot BC, Lynch JF. Familial atypical multiple mole-melanoma syndrome. J Med Genet. 1978;15(5):352-356.  https://doi.org/10.1136/jmg.15.5.352
  4. Elder DE, Goldman LI, Goldman SC, et al. Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer. 1980;46(8):1787-1794. https://doi.org/10.1002/1097-0142(19801015)46:8<1787::aid-cncr2820460816>3.0.co;2-s
  5. Nollet DJ. Clark’s nevus syndrome. Am J dermatopathol. 1986; 8(4):367.  https://doi.org/10.1097/00000372-198608000-00024
  6. Ackerman AB, Milde P. Naming acquired melanocytic nevi: common and dysplastic, normal and atypical, or Unna, Miescher, Spitz, and Clark? Am J Dermatopathol 1992;14:447-453.  https://doi.org/10.1097/00000372-199210000-00013
  7. Clemente C, Cochran AJ, Elder DE, et al. Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the world health organization melanoma programme. Hum Pathol. 1991;22(4):313-319.  https://doi.org/10.1016/0046-8177(91)90078-4
  8. Duncan LM, Berwick M, Bruijn JA, et al. Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study. J Invest Dermatol. 1993;100(3):S318-S321. https://doi.org/10.1038/jid.1993.55
  9. Goldsmith LA, Askin FB, Chang AE, et al. Diagnosis and treatment of early melanoma. JAMA. 1992;268(10): 1314-1319. https://doi.org/10.1001/jama.1992.03490100112037
  10. Shapiro M, Chren M, Levy RM, et al. Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists. J Cutan Pathol. 2004;31(8):523-530.  https://doi.org/10.1111/j.0303-6987.2004.00216.x
  11. Piepkorn MW, Barnhill RL, Elder DE, et al. The MPATH-dx reporting schema for melanocytic proliferations and melanoma. J Am Acad Dermatol. 2013;70(1):131-141.  https://doi.org/10.1016/j.jaad.2013.07.027
  12. Radick AC, Reisch LM, Shucard HL, et al. Terminology for melanocytic skin lesions and the MPATH-Dx classification schema: a survey of dermatopathologists. J Cutan Pathol. 2021;48(6):733-738.  https://doi.org/10.1111/cup.13873
  13. Shea CR, Vollmer RT, Prieto VG. Correlating architectural disorder and cytologic atypia in clark (dysplastic) melanocytic nevi. Hum Pathol. 1999;30(5):500-505.  https://doi.org/10.1016/S0046-8177(99)90191-0
  14. Elder DE, Massi D, Scolyer RA. WHO classification of skin tumours. 4th ed 11th volume. International Agency for Research on Cancer. 2018.
  15. Duncan LM, Berwick M, Bruijn JA, et al. Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study. J Invest Dermatol. 1993;100(3):S318-S321. https://doi.org/10.1038/jid.1993.55
  16. Elmore JG, Barnhill RL, Elder DE, et al. Pathologists’ diagnosis of invasive melanoma and melanocytic proliferations:observer accuracy and reproducibility study. BMJ. 2017;357:j2813. https://doi.org/10.1136/bmj.j2813
  17. Aydin UO, Yıldız P, Acar HC, Demirkesen C. Analysis of interobserver reproducibility in grading dysplastic nevi: results of the application of the 2018 world health organization grading criteria. J Cutan Pathol. 2022;49(4):343-349.  https://doi.org/10.1111/cup.14165
  18. Fallowfield ME, Cook MG. Pagetoid infiltration in primary cutaneous melanoma. Histopathology. 1992;20(5):417-420.  https://doi.org/10.1111/j.1365-2559.1992.tb01012.x
  19. Cramer SF. Pagetoid infiltration and pseudoinfiltrationanother point of view. Am J dermatopathology. 2002;24(5):451-452.  https://doi.org/10.1097/00000372-200210000-00020
  20. Welch HG, Mazer BL, Adamson AS. The rapid rise in cutaneous melanoma diagnoses. New Engl J Med. 2021;384(1):72-79.  https://doi.org/10.1056/NEJMsb2019760
  21. Frangos JE, Duncan LM, Piris A, et al. Increased diagnosis of thin superficial spreading melanomas: a 20-year study. J Am Acad Dermatol. 2011;67(3):387-394.  https://doi.org/10.1016/j.jaad.2011.10.026
  22. Van Deresch EP, Muir CS, Nectoux J, et al. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer. 1991;47(4):483-490.  https://doi.org/10.1002/ijc.2910470402
  23. Lozeau DF, Farber MJ, Lee JB. A nongrading histologic approach to clark (dysplastic) nevi: a potential to decrease the excision rate. J Am Acad Dermatol. 2015;74(1):68-74.  https://doi.org/10.1016/j.jaad.2015.09.030
  24. Annessi G, Cattaruzza MS, Abeni D, et al. Correlation between clinical atypia and histologic dysplasia in acquired melanocytic nevi. J Am Acad Dermatol. 2001;45(1):77-85.  https://doi.org/10.1067/mjd.2001.114580
  25. Klein LJ, Barr RJ. Histologic atypia in clinically benign nevi. A prospective study. J Am Acad Dermatol. 1990;22(2 Pt 1):275-282.  https://doi.org/10.1016/0190-9622(90)70037-I
  26. Gjersvik P, Veierød MB, Thompson A, et al. Histopathologic reassessment of melanoma and other melanocytic skin lesions excised in 2009 and 2018—2019. Tidsskr Nor Legeforen. 2022;142(15). https://doi.org/10.4045/tidsskr.22.0204
  27. Matthews NH, Li WQ, Qureshi AA, et al. Epidemiology of melanoma. In: Ward WH, Farma JM, red. Cutaneous melanoma: etiology and therapy. Brisbane: Codon Publications. 2017. https://doi.org/10.15586/codon.cutaneousmelanoma.2017.ch1
  28. Chang C, Murzaku EC, Penn L, et al. More skin, more sun, more tan, more melanoma. Am J Public Health 2014;104:e92-99.  https://doi.org/10.2105/AJPH.2014.302185

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.